IRIS Accounts Production v22.1.4.3 06028643 Board of Directors Board of Directors 1.1.21 31.12.21 31.12.21 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure060286432020-12-31060286432021-12-31060286432021-01-012021-12-31060286432019-12-31060286432020-01-012020-12-31060286432020-12-3106028643ns16:EnglandWales2021-01-012021-12-3106028643ns15:PoundSterling2021-01-012021-12-3106028643ns11:Director12021-01-012021-12-3106028643ns11:Director22021-01-012021-12-3106028643ns11:PrivateLimitedCompanyLtd2021-01-012021-12-3106028643ns11:SmallEntities2021-01-012021-12-3106028643ns11:AuditExempt-NoAccountantsReport2021-01-012021-12-3106028643ns11:SmallCompaniesRegimeForDirectorsReport2021-01-012021-12-3106028643ns11:SmallCompaniesRegimeForAccounts2021-01-012021-12-3106028643ns11:FullAccounts2021-01-012021-12-310602864312021-01-012021-12-3106028643ns6:CurrentFinancialInstruments2021-12-3106028643ns6:CurrentFinancialInstruments2020-12-3106028643ns6:Non-currentFinancialInstruments2021-12-3106028643ns6:Non-currentFinancialInstruments2020-12-3106028643ns6:ShareCapital2021-12-3106028643ns6:ShareCapital2020-12-3106028643ns6:RetainedEarningsAccumulatedLosses2021-12-3106028643ns6:RetainedEarningsAccumulatedLosses2020-12-3106028643ns11:RegisteredOffice2021-01-012021-12-310602864312021-01-012021-12-3106028643ns6:NetGoodwill2021-01-012021-12-3106028643ns6:IntangibleAssetsOtherThanGoodwill2021-01-012021-12-3106028643ns6:LandBuildings2021-01-012021-12-3106028643ns6:PlantMachinery2021-01-012021-12-3106028643ns6:NetGoodwill2020-12-3106028643ns6:NetGoodwill2021-12-3106028643ns6:NetGoodwill2020-12-3106028643ns6:LandBuildings2020-12-3106028643ns6:PlantMachinery2020-12-3106028643ns6:FurnitureFittings2020-12-3106028643ns6:MotorVehicles2020-12-3106028643ns6:FurnitureFittings2021-01-012021-12-3106028643ns6:MotorVehicles2021-01-012021-12-3106028643ns6:LandBuildings2021-12-3106028643ns6:PlantMachinery2021-12-3106028643ns6:FurnitureFittings2021-12-3106028643ns6:MotorVehicles2021-12-3106028643ns6:LandBuildings2020-12-3106028643ns6:PlantMachinery2020-12-3106028643ns6:FurnitureFittings2020-12-3106028643ns6:MotorVehicles2020-12-3106028643ns6:WithinOneYearns6:CurrentFinancialInstruments2021-12-3106028643ns6:WithinOneYearns6:CurrentFinancialInstruments2020-12-3106028643ns6:AfterOneYearns6:Non-currentFinancialInstruments2021-12-3106028643ns6:AfterOneYearns6:Non-currentFinancialInstruments2020-12-31
REGISTERED NUMBER: 06028643 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2021

for

Hellendoorn Healthcare Limited

Hellendoorn Healthcare Limited (Registered number: 06028643)

Contents of the Financial Statements
for the Year Ended 31 December 2021










Page

Balance Sheet 1

Notes to the Financial Statements 3


Hellendoorn Healthcare Limited (Registered number: 06028643)

Balance Sheet
31 December 2021

2021 2020
Notes £ £
Fixed assets
Intangible assets 4 42,000 44,000
Tangible assets 5 3,194,546 3,049,625
3,236,546 3,093,625

Current assets
Stocks 5,000 5,000
Debtors 6 549,822 623,592
Cash at bank and in hand 272,717 460,935
827,539 1,089,527
Creditors
Amounts falling due within one year 7 (506,083 ) (445,968 )
Net current assets 321,456 643,559
Total assets less current liabilities 3,558,002 3,737,184

Creditors
Amounts falling due after more than one
year

8

(2,879,830

)

(3,183,192

)

Provisions for liabilities (82,591 ) (99,759 )
Net assets 595,581 454,233

Capital and reserves
Called up share capital 99 99
Retained earnings 595,482 454,134
595,581 454,233

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Hellendoorn Healthcare Limited (Registered number: 06028643)

Balance Sheet - continued
31 December 2021


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 July 2022 and were signed on its behalf by:




Dr J W Hellendoorn - Director



Mrs H J Hellendoorn - Director


Hellendoorn Healthcare Limited (Registered number: 06028643)

Notes to the Financial Statements
for the Year Ended 31 December 2021


1. Statutory information

Hellendoorn Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 06028643

Registered office: Northbay House
Borrow Road
Oulton Broad
Lowestoft
NR32 3PW

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Critical accounting judgements and key sources of estimation uncertainty
The preparation of the financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Given the straightforward operations and financial position of the company, there are not considered to be any key sources of judgement or estimation uncertainty within these financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2018, is being amortised evenly over its estimated useful life of twenty five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - Straight line over 1 years
Plant and machinery etc - 25% on cost and 10% on cost

Hellendoorn Healthcare Limited (Registered number: 06028643)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021


2. Accounting policies - continued

Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received.

Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.


Hellendoorn Healthcare Limited (Registered number: 06028643)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021


2. Accounting policies - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. Employees and directors

The average number of employees during the year was 79 (2020 - 76 ) .

4. Intangible fixed assets
Goodwill
£
Cost
At 1 January 2021
and 31 December 2021 252,670
Amortisation
At 1 January 2021 208,670
Charge for year 2,000
At 31 December 2021 210,670
Net book value
At 31 December 2021 42,000
At 31 December 2020 44,000

Hellendoorn Healthcare Limited (Registered number: 06028643)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021


5. Tangible fixed assets
Fixtures
Freehold Plant and and Motor
property machinery fittings vehicles Totals
£ £ £ £ £
Cost
At 1 January 2021 3,120,895 80,639 480,323 128,913 3,810,770
Additions 194,739 500 40,303 53,310 288,852
At 31 December 2021 3,315,634 81,139 520,626 182,223 4,099,622
Depreciation
At 1 January 2021 430,085 71,700 227,405 31,955 761,145
Charge for year 61,814 3,121 34,551 44,445 143,931
At 31 December 2021 491,899 74,821 261,956 76,400 905,076
Net book value
At 31 December 2021 2,823,735 6,318 258,670 105,823 3,194,546
At 31 December 2020 2,690,810 8,939 252,918 96,958 3,049,625

6. Debtors
2021 2020
£ £
Amounts falling due within one year:
Other debtors 538,822 603,592

Amounts falling due after more than one year:
Trade debtors 11,000 20,000

Aggregate amounts 549,822 623,592

7. Creditors: amounts falling due within one year
2021 2020
£ £
Bank loans and overdrafts 281,993 237,399
Trade creditors 30,495 20,475
Taxation and social security 115,056 136,486
Other creditors 78,539 51,608
506,083 445,968

Hellendoorn Healthcare Limited (Registered number: 06028643)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021


8. Creditors: amounts falling due after more than one year
2021 2020
£ £
Bank loans 2,809,813 3,091,807
Other creditors 70,017 91,385
2,879,830 3,183,192

9. Leasing agreements
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.